Cardinal Health, Inc (CAH) concluded trading on Thursday at a closing price of $160.52, with 2.97 million shares of worth about $476.36 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 32.03% during that period and on June 12, 2025 the price saw a gain of about 4.55%. Currently the company’s common shares owned by public are about 239.00M shares, out of which, 238.00M shares are available for trading.
Stock saw a price change of 4.15% in past 5 days and over the past one month there was a price change of 8.27%. Year-to-date (YTD), CAH shares are showing a performance of 35.72% which increased to 62.40% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $93.17 but also hit the highest price of $157.82 during that period. The average intraday trading volume for Cardinal Health, Inc shares is 2.43 million. The stock is currently trading 4.10% above its 20-day simple moving average (SMA20), while that difference is up 10.64% for SMA50 and it goes to 26.87% higher than SMA200.
Cardinal Health, Inc (NYSE: CAH) currently have 239.00M outstanding shares and institutions hold larger chunk of about 88.40% of that.
The stock has a current market capitalization of $38.31B and its 3Y-monthly beta is at 0.68. PE ratio of stock for trailing 12 months is 25.07, while it has posted earnings per share of $6.40 in the same period. Its PEG reads 2.31 and has Quick Ratio of 0.50. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CAH, volatility over the week remained 2.39% while standing at 1.28% over the month.
Stock’s fiscal year EPS is expected to rise by 8.18% while it is estimated to increase by 12.39% in next year. EPS is likely to grow at an annualized rate of 10.85% for next 5-years, compared to annual growth of -5.30% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Wells Fargo on June 03, 2025 offering an Overweight rating for the stock and assigned a target price of $179 to it. Coverage by Jefferies stated Cardinal Health, Inc (CAH) stock as a Buy in their note to investors on February 05, 2025, suggesting a price target of $150 for the stock. On January 08, 2025, TD Cowen Upgrade their recommendations, while on January 07, 2025, Evercore ISI Upgrade their ratings for the stock with a price target of $140. Stock get a Buy rating from BofA Securities on January 06, 2025.
